Skip to content
Screener

Treace Medical Concepts, Inc. TMCI Q2 2026 earnings

Reported August 7, 2026 · Before market open

Revenue$45.4MBeat by $1.4M
EPS-$0.24Beat by $0.06
Revenue estimate$44.0M
EPS estimate-$0.30
“We are pleased with our second quarter results which were driven by accelerating year-over-year case volumes and market share gains resulting from increasing surgeon adoption of our comprehensive bunion portfolio as well as our expanding line of new technologies - now providing us access to a broader range of procedures throughout the foot & ankle. We continue to focus on investing in growth initiatives to leverage our expanded portfolio, while driving profitability, positioning us for stronger growth in the second half of the year.”
John T. Treace

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$47.7M
EPS estimate-$0.26

Financials

Q2 2026

Income statement

See full
Revenue$45.4M-4.2%
Gross profit$35.6M-5.7%
Operating income-$15.0M+11.9%
Net income-$15.9M+8.8%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$12.6M+56.6%
Total debt$72.7M+3.7%
Total equity$67.7M-30.6%
Total assets$181.1M-12.3%

Cash flow

See full
CapEx$2.2M-53.8%
Free cash flow-$6.9M+11.7%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$296.56M-33.3%
Enterprise value$356.64M-29.6%
P/S1.4×-0.6×

Profitability

See full
Gross margin79.5%-0.7pp
Operating margin-26.2%+5.3pp
Net margin-29%+10.2pp
FCF margin-12.2%-1.2pp

Returns & leverage

See full
Return on equity-72%+82.9pp
Debt / equity1.1×+0.4×
Current ratio2.9×-0.6×

FAQ

When did Treace Medical Concepts, Inc. report Q2 2026 earnings?
Treace Medical Concepts, Inc. (TMCI) reported Q2 2026 earnings on August 7, 2026 before market open.
What were Treace Medical Concepts, Inc.'s Q2 2026 revenue and EPS?
Treace Medical Concepts, Inc. reported revenue of $45.4M and eps of $-0.24 for Q2 2026.
Did Treace Medical Concepts, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $44.0M by $1.4M. EPS beat the consensus estimate of $-0.30 by $0.06.
How did Treace Medical Concepts, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 4.2% from $47.4M a year earlier and eps grew 14.3% from $-0.28.
Where can I find Treace Medical Concepts, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001630627-26-000017) and the 10-Q periodic report (0001630627-26-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.